Back to Search
ROBERT BECKER, M.D. PH.D.
M.D. PH.D.
Anesthesiology Physician
NPI: 1871781286IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
A104625(CA)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 2006
Research & Publications (20)
Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?
PMID 19142109·J Clin Psychopharmacol·2009
8-other
Biological and pharmacological aspects of perioperative hemorrhagic complications associated with oral platelet-directed antithrombotic agents. Focus on isolated coronary artery bypass grafting and oral irreversible P2Y(12) receptor antagonists.
PMID 18937965·Thromb Res·2009
6-review
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study.
PMID 19286091·Lancet·2009
3-trial
Resurrecting clinical pharmacology as a context for Alzheimer disease drug development.
PMID 19199879·Curr Alzheimer Res·2009
6-review
Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the carboxyl-terminal domain of RNA polymerase II.
PMID 18550522·J Biol Chem·2008
8-other
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
PMID 18574276·Chest·2008
6-review
The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
PMID 18574278·Chest·2008
6-review
Alzheimer's disease drug development in 2008 and beyond: problems and opportunities.
PMID 18690832·Curr Alzheimer Res·2008
6-review
Thrombogenesis in atrial fibrillation: contributing mechanisms and natural history.
PMID 18931889·J Thromb Thrombolysis·2008
8-other
Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?
PMID 18953116·J Alzheimers Dis·2008
6-review
Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K.
PMID 18490383·FASEB J·2008
8-other
Alzheimer's disease drug development: old problems require new priorities.
PMID 19128207·CNS Neurol Disord Drug Targets·2008
6-review
Clinical pharmacokinetics and pharmacodynamics of insulin glulisine.
PMID 18076215·Clin Pharmacokinet·2008
6-review
Focus on thrombosis : Applying management guidelines in clinical practice.
PMID 17510753·J Thromb Thrombolysis·2007
6-review
Tiered toxicity testing: evaluation of toxicity-based decision triggers for human health hazard characterization.
PMID 17689851·Food Chem Toxicol·2007
4-observational
Nucleic acid aptamers and their complimentary antidotes. Entering an era of antithrombotic pharmacobiologic therapy.
PMID 18060250·Hamostaseologie·2007
8-other
Insulin glulisine complementing basal insulins: a review of structure and activity.
PMID 17316105·Diabetes Technol Ther·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 PASTEUR DR, ROOM H3580
STANFORD, CA 94305 - Phone
- (650) 723-7377
Quick Facts
- NPI
- 1871781286
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 20
- Publications
- 20
Are you this provider?
Claim Your Profile